Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Holdener

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Investigational New Drugs|January 1, 1985
Epirubicin in colorectal cancer. A phase II study of the early clinical trials group (EORTC)E E Holdener, H H Hansen, H Høst, et al.
Schweizerische Medizinische Wochenschrift|September 30, 1989
[Therapy of thrombocytosis in myeloproliferative syndromes using recombinant interferon-alpha-2a]A Tichelli, A Gratwohl, F Delacrétaz, et al.
Schweizerische Medizinische Wochenschrift|March 22, 1986
[Malignant pericardial effusion--a sign of unfavorable prognosis?]E E Holdener, D H Ryser, K Schaermeli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1983
Phase II study of doxifluridine in advanced colorectal adenocarcinomaR Abele, P Alberto, S Kaplan, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Primary hypothyroidism associated with interleukin-2 and interferon alpha-2 therapy of melanoma and renal carcinomaS Scalzo, A Gengaro, G Boccoli, et al.
Blut|January 1, 1989
Treatment of thrombocytosis in myeloproliferative disorders with interferon alpha-2aA Tichelli, A Gratwohl, C Berger, et al.
Cancer Treatment Reports|September 1, 1984
Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposideR A Joss, P Alberto, J P Obrecht, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1992
Recombinant interferon alfa-2a with or without vinblastine in metastatic renal cell carcinoma: results of a European multi-center phase III studyS D Fosså, G Martinelli, U Otto, et al.
Journal of the National Cancer Institute|February 19, 1992
13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervixS M Lippman, J J Kavanagh, M Paredes-Espinoza, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase II trial of anaxirone (TGU) in advanced colorectal cancer: an EORTC Early Clinical Trials Group (ECTG) studyE E Holdener, M Clavel, C Sessa, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Investigational New Drugs|January 1, 1985
Epirubicin in colorectal cancer. A phase II study of the early clinical trials group (EORTC)E E Holdener, H H Hansen, H Høst, et al.
Schweizerische Medizinische Wochenschrift|September 30, 1989
[Therapy of thrombocytosis in myeloproliferative syndromes using recombinant interferon-alpha-2a]A Tichelli, A Gratwohl, F Delacrétaz, et al.
Schweizerische Medizinische Wochenschrift|March 22, 1986
[Malignant pericardial effusion--a sign of unfavorable prognosis?]E E Holdener, D H Ryser, K Schaermeli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1983
Phase II study of doxifluridine in advanced colorectal adenocarcinomaR Abele, P Alberto, S Kaplan, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Primary hypothyroidism associated with interleukin-2 and interferon alpha-2 therapy of melanoma and renal carcinomaS Scalzo, A Gengaro, G Boccoli, et al.
Blut|January 1, 1989
Treatment of thrombocytosis in myeloproliferative disorders with interferon alpha-2aA Tichelli, A Gratwohl, C Berger, et al.
Cancer Treatment Reports|September 1, 1984
Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposideR A Joss, P Alberto, J P Obrecht, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1992
Recombinant interferon alfa-2a with or without vinblastine in metastatic renal cell carcinoma: results of a European multi-center phase III studyS D Fosså, G Martinelli, U Otto, et al.
Journal of the National Cancer Institute|February 19, 1992
13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervixS M Lippman, J J Kavanagh, M Paredes-Espinoza, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase II trial of anaxirone (TGU) in advanced colorectal cancer: an EORTC Early Clinical Trials Group (ECTG) studyE E Holdener, M Clavel, C Sessa, et al.
Pageof 4